Table 1.
Clinical features of eyes with stage 4 retinopathy of prematurity
| stage 4A (35 eyes of 25 patients) |
stage 4B (7 eyes of 6 patients) |
||
|---|---|---|---|
| Sex | Number of patients (%) | ||
| Girl | 14 (56.0) | 3 (50.0) | |
| Boy | 11 (44.0) | 3 (50.0) | |
| GA (day) | Median | 175.0 | 180.0 |
| Range | 154—190 | 161—238 | |
| BW (g) | Median | 640.0 | 710.5 |
| Range | 459—962 | 514—1,652 | |
| PCA at primary vitrectomy (days) | Median | 289.5 | 337 |
| Range | 236 – 465 | 254—410 | |
| Number of vitrectomy | Mean | 1.1 | 1.4 |
| Range | 1–2 | 1–2 | |
| Intravitreal bevacizumab injection | Number of eyes (%) | ||
| Yes | 7 (20.0) | 1 (14.2) | |
| No | 28 (80.0) | 6 (85.7) | |
| PO lens status | Number of eyes (%) | ||
| Phakia | 26 (74.3) | 5 (71.4) | |
| Aphakia | 9 (25.7) | 2 (28.6) |
GA Gestational age (day), BW Birth weight (g), PCA post-conceptional age, PO post-operative